Nano-x Imaging Ltd · NASDAQ:NNOX
Nano-x Imaging — Investor Day (September 2024)
37 slides from Nano-x Imaging's investor day presentation, Sep 23, 2024
Slide 1: Nanox Analyst Day 2024
September 2024 % OOK is % % SOK ras NANOX
Slide 2: Nanox Analyst Day 2024 and its subsidiaries
Nanox Analyst Day 2024 and its subsidiaries
Slide 3: On the Agenda
Fy rancx On the Agenda Opening Remarks Expanding Our reach U.S. Business update Recent Key Takeaways Nanox Commercial Strategy Regulatory Pathway | Leveraging AI Al Proven Results New Al Cardiac Solution V2.0 Nanox.ARC Al | Clinical Performance R&D Center Nanox.ARC Clinical Proven results | Q&A Sess
Slide 4: wip
wip ] livid $
Slide 5: Offering a seamless end-to-end solution, from scan to diagnosis
Nanox Analyst Day 2024 5 Offering a seamless end-to-end solution, from scan to diagnosis Providing advanced diagnostic imaging capabilities and elevating overall patient care
Slide 6: Expanding Our Reach
=) Expanding Our Reach = Offering Nanox technology both within and Offerheycaseosnitael $ettiag_to-end solution, from scan to diagnosis dam Leveraging Al PO vidia adwannadiciagnesti@proves global ima Citra tragaalpylétha spatieh setcates overall patient care Robust Clinical Performance Prioritizing
Slide 7: Slide 7
Slide 8: Cantor Global Healthcare Conference
Cantor Global Healthcare Conference
Slide 9: U.S. Business Update
GY nanoxs Nanox Analyst Day 2024] 9 U.S. Business Update Florida Advanced the US deployment program for the Nanox.ARC technology, with systems installed in eight states, and a robust sales pipeline.
Slide 10: • • • • • •
Nanox Analyst Day 2024 • • • • • •
Slide 11: Slide 11
Slide 12: Scan distribution by body part
Nanox Analyst Day 2024 Chest 30% Hand 29% Head 5% Pelvis 4% Leg 13% Abdomen 6% Spine 13%
Slide 13: Customer testimonials
Nanox Analyst Day 2024 Sherri Donaldson, COO at DRI, Kansas Dr. Todd Goldman, Chiropractor at TCC, New York
Slide 14: Regulatory Pathway
Regulatory Pathway ) NANOXx
Slide 15: U.S. FDA 510(k)
Nanox Analyst Day 2024 U.S. FDA 510(k)
Slide 16: Slide 16
Slide 17: Clinician testimonials
Nanox Analyst Day 2024 Alexis Kurek, PhD. MA.CCC - SLP Population Health Operations Specialist Dr. Madubata, MD Non - Invasive Cardiologist Einstein Medical Center, Philadelphia Brittany Weber,MD Phd. Director, Cardio - Rheumatology Clinic, Division of Preventive Cardiology, Division of Cardiovascul
Slide 18: Radiologists Radiologists + AI tool
Nanox Analyst Day 2024 Radiologists Radiologists + AI tool
Slide 19: Early findings study on spine fracture detection
Nanox Analyst Day 2024 Early findings study, show in the ADOPT that Nanox.AI software improves the detection of spine fractures, an early sign of osteoporosis, outperforming UK National Health Service national average . ”
Slide 20: Coronary calcium AI solution
Detected Calcium ef 1000+ Analyzes non-contrast, non-ECG gated chest CT scans. Automatically measures calcified plaque in the coronary arteries. Output key images with visualization of the calcified plaques within the coronary arteries. Analyst Day 202: Index bar to indicate the level within the cat
Slide 21: AI Cardiac Solution HealthCCSng V2.0
B nanox Nanox Analyst Day 2024 | 21 fa) 9 Al Cardiac Solution — HealthC@Sng V2.0 Upgraded Version of Advanced Al Cardiac Solution Detected Calcium HealthCCSng V2.0 introduce several features 1000+ ca aaa 5 400 Al: Coronary Artery Calcium Al: Coronary Artery Calcium MEDIUM Low 100 Ed rmon i <<“ ik |
Slide 22: Pulmonary nodule AI application for Nanox.ARC X
Nanox Analyst Day 2024 Pulmonary nodule is expected to be the first AI application for the new Nanox.ARC X, automatically identifying patients with pulmonary nodules aiming to raise report rates across US
Slide 23: Dr. Nogah Shabshin
Dr. Nogah Shabshin Department of Radiology , Penn Wega Department of Radiolo: Head of Tomosynth
Slide 24: Patents and Future Roadmap
Nanox Analyst Day 2024 | 24 Nanox 14 (40+) Patents Patents families NanoxAl 14 (-30) Patents Patents families Future Roadmap Multi Beam Stationary CT OEM
Slide 25: • • • • • •
Nanox Analyst Day 2024 • • • • • •
Slide 26: Clinical Trial 08.2024: Preliminary Results for Chest DTS
Gy nanox \ Nanox Ardlyst Day 2024 26 Clinical Trial 08. 2024: ——j cence sun Preliminary Results for Chest tDTS— wer ® Missed lesions on DTS: Oo * Short learning curve * The reading radiologists had no prior experience in chest DTS. Taken from Nanox’s whitepaper, August 2024 https://edn.prod.website-
Slide 27: Clinical Trial: Preliminary Results for Chest
Clinical Trial: — Preliminary Results for Chest X-Ray Nanox.ARC A 3mm nodule is seen in the right On a different DTS slice a 1.2 cm upper lobe on DTS only (arrow). nodule is clearly seen (arrow) while The nodule is not seen on the 2D ona conventional 2D radiograph it radiographs even retrospectively
Slide 28: Clinical Trial 08.2024: Preliminary Results for Chest
Cy wero 7 yy Nanox Analyst Day 2024 Clinical Trial 08.2024 : Preliminary Results for Chest ~~ Qs RABIN MEDICAL CENTER (@® BEILINSON + HASHARON X-Ray On CXR, the lesion is noticeable however no characterization is available The lesion is clearly noticeable and its cavitary nature is easily seen. Slic
Slide 29: • • • • • •
Nanox Analyst Day 2024 • • • • • •
Slide 30: Clinical Trial Initial Results for MSK in Shamir Medical Center
Gy ranox a , Nanox Analyst Day 2024) 30 Clinical Trial Initial Results for MSK in Shamir Medical Center = j ~~ SHAMIR MEDICAL CENTER X-Ray On XRAY - The cast obscures fine bony details. There is a suspected subluxation of the 2nd MTP. Nanox.ARC of the 2nd MTT (middle) as well as an additional displa
Slide 31: Device is not yet regulatory approved
Device is not yet regulatory approved | Concept for educational purposes only
Slide 32: Nanox.ARC X
= P< Nanox.ARC X Nanox.ARC X is our future 3D digital multi-source tomosynthesis system. The improved design results in a smaller footprint. Future capabilities such as image enhancement and synthetic 2D, as well as new intended uses can be upgraded remotely and immediately upon receipt of regulator
Slide 33: Potential Benefits of Nanox.ARC X
Cy vm Nanox Analyst Day 2024 | 33, Potential Benefits of Nanox.ARC X Smaller footprint 1 a unified single-unit system. No construction is needed, turn any standard X-Ray shielded room to a Nanox.ARC X room. Multi- Axis tomographic system 5 cold cathode tubes are equally distributed above the patient
Slide 34: Design
Nanox Analyst Day Design Nanox.ARC Nanox.ARC X Industrial Design Simplified metal parts Sleek Design Device is not yet regulatory approved | Concept device for Illustrative purposes only
Slide 35: Industrial Design
Nanox Analyst Day 2024 Industrial Design Nanox.ARC Nanox.ARC X Length: 2.7 m Length:2.1 m Height: 1.45 m Height: 1.59 m Patient table: lays on wheels Patient table: flying, lay on chassis Device is not yet regulatory approved | Concept device for Illustrative purposes only
Slide 36: Industrial Design
Nanox Analyst Day 2024 Industrial Design —— Nanox.ARC Nanox.ARC X External cabinet Cabinet under the system table Device is not yet regulatory approved | Concept device for Illustrative purposes only
Slide 37: Thank You
Thank You = NANOXx